Could veterans of war, rape victims and other people who have seen horrific crimes someday have the traumatic memories that haunt them weakened in their brains? In a new study, David Glanzman, UCLA professor of Integrative Biology and Physiology, and his colleagues report a discovery that may make the reduction of such memories a reality.
This recent study on squamous cell cancers by Andrew White, postdoctoral fellow, and William Lowry, assistant professor, in the Department of Molecular, Cell and Developmental Biology, could result in new strategies to treat and potentially prevent the disease.
A UCLA research team led by Leonard H. Rome and including Daniel B. Toso and Z. Hong Zhou from the UCLA Department of Microbiology, Immunology and Molecular Genetics, have developed a new and potentially far more effective means of targeted drug delivery using nanotechnology.
Life Sciences professor Jeffrey H. Miller was today elected a Fellow of the prestigious American Academy of Arts and Sciences. Previous Fellows have included George Washington, Benjamin Franklin, Ralph Waldo Emerson, Albert Einstein and Winston Churchill.
Robert Bjork, distinguished professor of psychology and co-principal investigator at the Bjork Learning and Forgetting Lab at UCLA, was quoted on Monday in a New York Times article on new research about how we learn and remember.
Ladan Shams, UCLA assistant professor of Psychology, recently published a study of how brain corrects perceptual errors. These findings may lead to better hearing aids and robotic technology.
Kerri Johnson, UCLA assistant professor of communication studies and psychology, was quoted in an ABC News online article about a dating website that matches couples based on their facial similarities.
U.S. News & World reports on research by Alan Castel, UCLA assistant professor of cognitive psychology, and colleagues exploring the dynamics between memory and emotional states.
A study co-authored by James Lloyd-Smith, UCLA assistant professor of Ecology and Evolutionary Biology, and U.C. San Diego biochemist Leor Weinberger found that, over 30 years, therapeutic interfering particles (TIPS) could reduce the number of people in Sub-Saharan Africa infected with HIV to one-thirtieth of the current level.
